These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8248750)

  • 21. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T; Inoue Y; Morikawa A
    Nihon Rinsho; 2008 Feb; 66(2):332-7. PubMed ID: 18260333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004.
    Du ZD; Zhao D; Du J; Zhang YL; Lin Y; Liu C; Zhang T;
    Pediatr Infect Dis J; 2007 May; 26(5):449-51. PubMed ID: 17468660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kawasaki disease.
    Shulman ST; Bendet M
    Compr Ther; 1997 Jan; 23(1):13-8. PubMed ID: 9067077
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical- epidemiological characteristics and predictors of coronary complications in children of Argentina with Kawasaki disease].
    Melonari P; Abate H; Llano López LH; Cutlca RJ; Apaz MT; Battagliotti C; Vilca I; Cancellara A; Calvari M; Ellis A; Collia AG; Flynn LP; Aletti A; Lazarte G; Petricca J; Tonetto IP; Santillán A; Brusadín M; Gaiano A
    Rev Chilena Infectol; 2019 Oct; 36(5):636-641. PubMed ID: 31859805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.
    Ae R; Makino N; Kosami K; Kuwabara M; Matsubara Y; Nakamura Y
    J Pediatr; 2020 Oct; 225():23-29.e2. PubMed ID: 32454114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term issues in Kawasaki disease.
    Gersony WM
    J Pediatr; 1992 Nov; 121(5 Pt 1):731-3. PubMed ID: 1432422
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of Kawasaki disease in the British Isles.
    Dhillon R; Newton L; Rudd PT; Hall SM
    Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Kawasaki disease incidence rising in Chandigarh, North India?
    Singh S; Aulakh R; Bhalla AK; Suri D; Manojkumar R; Narula N; Burns JC
    Arch Dis Child; 2011 Feb; 96(2):137-40. PubMed ID: 20923951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-term outcome of patients with Kawasaki disease, single-centre experience.
    Gillebert C; Vandeyk K; Troost E; Gewillig M; Budts W
    Acta Cardiol; 2010 Jun; 65(3):291-5. PubMed ID: 20666266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of coronary artery aneurysm to obstructive lesion and the role of collateral vessels in myocardial perfusion in patients with Kawasaki disease.
    Onouchi Z; Hamaoka K; Kamiya Y; Hayashi S; Ohmochi Y; Sakata K; Shiraishi I; Hayano T; Fukumochi H
    J Am Coll Cardiol; 1993 Jan; 21(1):158-62. PubMed ID: 8417058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of Kawasaki disease.
    Sagraves R
    J Pediatr Health Care; 1993; 7(6):278-82. PubMed ID: 8106928
    [No Abstract]   [Full Text] [Related]  

  • 36. Kawasaki syndrome.
    Rowley AH; Gonzalez-Crussi F; Shulman ST
    Rev Infect Dis; 1988; 10(1):1-15. PubMed ID: 3281216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An overview of the 10(th) International Kawasaki Disease Symposium].
    Chen SB; Huang MR
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):714-7. PubMed ID: 23158827
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictive value of red blood cell distribution width for coronary artery lesions in patients with Kawasaki disease.
    Xu H; Fu S; Wang W; Zhang Q; Hu J; Gao L; Zhu W; Gong F
    Cardiol Young; 2016 Aug; 26(6):1151-7. PubMed ID: 26435202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
    Ruan Y; Ye B; Zhao X
    Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kawasaki disease: a clinical and epidemiological study of 70 children in Brazil.
    Magalhães CM; Vasconcelos PA; Pereira MR; Alves NR; Gandolfi L; Pratesi R
    Trop Doct; 2009 Apr; 39(2):99-101. PubMed ID: 19299294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.